Oppenheimer analysts provided some “color for Fundamental focus calls” to five buy-rated stocks in an uptrend.

John Newman, an analyst from Canaccord Genuity, maintained the Buy rating on BioNTech SE (BNTX – Research Report). The associated price ...

Corcept Therapeutics (CORT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

In a report released today, Joseph Moore from Morgan Stanley maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report), with ...

The Pacer US Cash Cows 100 ETF, or COWZ ETF, invests in U.S. companies with high free-cash-flow yields. Find out how to ...

One challenge facing Carnival stock today is that because 2024 has been so strong, the company will have a tough act to ...

List today:American Assets Trust, Inc. AAT: This self-administered real estate investment trust has seen the Zacks Consensus ...

I suggest day traders maintain a stock-specific approach and find shares that look strong on the technical chart pattern. Finding breakout stocks for intraday trading can be a good option." Regarding ...

Sumeet Bagadia, executive director of Choice Broking, advised purchasing two stocks on Tuesday, November 5th, following the ...

We recently published a list of 10 Largest Gambling Stocks of 2024. In this article, we are going to take a look at where ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-N) from The Globe and Mail including charting and trades.

In October, FIIs have been on a selling spree and have sold shares worth Rs 85,000 crore. However, DIIs have been acting as a strong counterforce by buying shares worth Rs 1.07 lakh crore.